Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration

NCT05011474 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc

Interventions

BIOLOGICAL: administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3

Sponsor

Inbo Han